Carles Iniesta-Navalón
16PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Jan 22, 2026
Utility of tolerance assays for real-time management of infliximab infusion reactions.Rocío Guzmán-Laiz, Carles Iniesta-Navalón, Manuel Ríos-Saorín
|Nov 21, 2025
STRATIfy-PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti-TNF-treated patient.Carles Iniesta-Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo
|Nov 15, 2025
Immunogenicity phenotypes and reversal of pharmacokinetic impact in anti-TNF-treated immune-mediated diseases: a real-world study.Rocío Guzmán-Laiz, Carles Iniesta-Navalón, Manuel Ríos-Saorín
|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull
|Jul 04, 2025
Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases.Patricia Ortiz-Fernández, Carles Iniesta-Navalón, Elena Urbieta-Sanz
|May 09, 2025
Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab.Carles Iniesta-Navalón, Manuel Ríos-Saorín, Rebeca Añez-Castaño
Pageof 3
Frequent Collaborators
5 joint publications
Mayte Gil-Candel
1 joint publications
Juan Jose Gascón-Cánovas
1 joint publications
Zenewton André da Silva Gama
1 joint publications
José Francisco Sánchez-Ruiz
1 joint publications
Erick Angelico Gutiérrez-Estrada
1 joint publications
Ernesto De-la-Cruz-Sánchez
1 joint publications
Owen Harrington-Fernández
1 joint publications
Antonio Solana-Altabella
1 joint publications
Maria Chovi-Trull
1 joint publications
Marina Lopez-Nogueroles
